drugset / Trial / NCT05361421

Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

NCT05361421

Phase 4 Active not recruiting 1200 enrolled Yonsei University
RandomizedParallel-groupOpen-labelTreatment

Summary

Although there have been studies regarding intensive lowering of low-density lipoprotein (LDL)-cholesterol with high intensity statins in patients with cardiovascular disease, elderly patients were either excluded or accounted only a small portion of study subjects. Therefore, this study sought to compare the clinical outcomes according to the LDL-cholesterol therapy strategy (intensive targeting \[LDL-cholesterol goal of \<55mg/dL\] vs. conventional therapy \[moderate intensity statin therapy\]) in elderly patients with ≥75 years and documented cardiovascular disease.

Timeline

Start
2022-07-19
Primary completion
2027-10-15
Completion
2027-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 5 mg
Subject Atorvastatin Small molecule 10 mg
Subject Atorvastatin Small molecule 20 mg
Subject Atorvastatin Small molecule 40 mg
Subject Atorvastatin Small molecule 80 mg
Subject Ezetimibe Unknown